30 March 2021 | News
C-CAMP is looking to deploy these technologies in public healthcare facilities
Image credit- shutterstock.com
Centre for Cellular and Molecular Platforms (C-CAMP) has inked a pact with SBI Foundation for CSR support towards boosting existing public healthcare efforts in light of a resurgent COVID-19 pandemic.
Through this joint effort, they will bring two new, potentially life-saving technologies in assisted respiratory device and contactless remote vitals monitoring categories for deployment across the country.
The innovations developed by two of India’s leading medtech startups, Coeo Labs and Turtle Shell Technologies will be deployed in several cities worst affected by the pandemic.
The two products selected for the proposed field deployment are Saans Pro, Continuous positive airway pressure (CPAP) device that provides non-invasive respiratory support, by Coeo Labs and Dozee, India’s first contactless vital monitoring device by Turtle Shell Technologies.
Both are Bengaluru based C-CAMP portfolio start-ups. C-CAMP is looking to deploy these technologies in public healthcare facilities including Primary Health Centres, hospitals, and quarantine centres to provide better critical care for in-patients and continuous remote monitoring for asymptomatic patients, high-risk groups remotely. Additionally, both are expected to reduce caregiving burden on frontline healthcare workers.
SBI Foundation, the CSR subsidiary of State Bank of India, has been undertaking CSR initiatives with a vision to improve the socio-economic well-being of the society.